Michael Richman - 22 Jun 2022 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Role
Director
Signature
/s/ Ahmed S. Mousa, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 19:02:42 UTC
Previous filing
02 Feb 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 22 Jun 2022 Common Stock 40,000 $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to 100% of the underlying shares on the date of the Company's 2023 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney